CellCept, Mycophenolate

CellCept, Mycophenolate Newswire

Comprehensive Real-Time News Feed for CellCept, Mycophenolate (generic).

Results 1 - 20 of 51 in CellCept, Mycophenolate (generic)

  1. A neurologist's guide to safe use of immunomodulatory therapies.Read the original story

    Monday Jan 12 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Increased understanding of the pathogenesis of immune-mediated neurologic conditions with concomitant development of new therapeutic agents modulating various aspects of the immune system has resulted in the use of innovative therapies in the treatment of these diseases.

    Comment?

  2. Insights into the role of genetic variants in kidney diseaseRead the original story w/Photo

    Monday Jan 12 | Medical News Today

    New research provides insights into the ties between certain genetic variants and kidney disease in African Americans. The genetic association is one of the strongest ever reported for a common disease, and these latest findings may help improve diagnosis and treatment.

    Comment?

  3. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.Read the original story

    Saturday Jan 10 | CiteULike

    Idiopathic membranous nephropathy is the most common form of nephrotic syndrome in adults. The disease shows a benign or indolent course in the majority of patients, with a rate of spontaneous complete or partial remission of nephrotic syndrome as high as 30% or more.

    Comment?

  4. Study provides insights into the role of genetic variants in kidney diseaseRead the original story w/Photo

    Thursday Jan 8 | PhysOrg Weblog

    New research provides insights into the ties between certain genetic variants and kidney disease in African Americans. The genetic association is one of the strongest ever reported for a common disease, and these latest findings may help improve diagnosis and treatment.

    Comment?

  5. Study Provides Insights Into the Role of Genetic Variants in Kidney DiseaseRead the original story

    Thursday Jan 8 | Newswise

    Highlights a Among patients with a kidney disease called focal segmental glomerulosclerosis, those who had certain genetic variants tended to have more advanced disease when they were diagnosed. a Patients with the variants responded to cyclosporine and mycophenolate mofetil immunosuppressant treatments just as well as other patients.

    Comment?

  6. Rituximab for the treatment of IgG4-related orbital disease: experience from five casesRead the original story w/Photo

    Wednesday Jan 7 | Eye

    Correspondence: A Wu, South Australian Institute of Ophthalmology, Royal Adelaide Hospital, Level 8, East Wing, Adelaide, SA 5000, Australia. Tel: +61 8 8222 2729; Fax: +61 8 8222 2741.

    Comment?

  7. Haploidentical hematopoietic SCT may be superior to conventional...Read the original story

    Wednesday Jan 7 | Bone Marrow Transplantation

    Correspondence: Professor X-J Huang, Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Peking-Tsinghua Center for Life Sciences, 11 Xizhimen South Street, Beijing 100044, China. E-mail: huangxiaojun@bjmu.edu.cn of high-risk adult ALL patients in their first complete remission are able to receive an HLA-matched sibling stem cell transplant.

    Comment?

  8. DLI after haploidentical BMT with post-transplant CYRead the original story

    Wednesday Jan 7 | Bone Marrow Transplantation

    Correspondence: Dr A Bacigalupo, Divisione Ematologia e Trapianto di Midollo Osseo, IRCCS San Martino, Largo Rosanna Benzi 10, 16132 Genova, Italy. E-mail: andrea.bacigalupo@hsanmartino.it Forty-two patients relapsing after an unmanipulated haploidentical BM transplant and post-transplant CY , were given 108 DLI, with median interval from transplant of 266 days .

    Comment?

  9. Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus...Read the original story

    Wednesday Jan 7 | Bone Marrow Transplantation

    E-mail: ratanath@karmanos.org We performed a retrospective analysis of the outcome of 197 consecutive unrelated donor transplant recipients who received GVHD prophylaxis either TM regimen or TM , P <0.001) and more favorable global chronic GVHD severity . Univariate analyses showed improved OS and PFS of patients who received TM kg given in conjunction with TM improved GVHD prophylaxis without increased risk of relapse.

    Comment?

  10. KIR and HLA genotypes have no identifiable role in single-unit...Read the original story

    Wednesday Jan 7 | Bone Marrow Transplantation

    Umbilical cord blood is widely used as an alternative hematopoietic stem cell source. The use of double-unit CB grafts is a common strategy to augment graft cell dose and successfully leads to engraftment by a single unit.

    Comment?

  11. Multitarget Therapy for Induction Treatment of Lupus NephritisRead the original story

    Monday Jan 5 | Annals of Internal Medicine

    The full report is titled "Multitarget Therapy for Induction Treatment of Lupus Nephritis. A Randomized Trial."

    Comment?

  12. Mononeuritis multiplex as the first presentation of refractory sarcoidosis responsive to etanerceptRead the original story

    Dec 10, 2014 | BioMed Central

    BackgroundSeveral disorders may present with mononeuritis multiplex and the etiological diagnosis can be challenging.Case presentationWe report a 42-year old female who presented with severe lower limb neuropathic pain, asymmetric weakness and sensory impairment and was diagnosed with mononeuritis multiplex. Biopsy showed a granulomatous vasculitic process with eosinophils, scarce granulomata and axonal neuropathy and granulomatosis with poliangiitis was assumed.

    Comment?

  13. Multitarget Therapy for Induction Treatment of Lupus Nephritis: A Randomized, Controlled Trial.Read the original story

    Dec 5, 2014 | CiteULike

    Treatment of lupus nephritis remains challenging. To assess the efficacy and safety of a multitarget therapy consisting of tacrolimus, mycophenolate mofetil, and steroid compared with intravenous cyclophosphamide and steroid as induction therapy for LN.

    Comment?

  14. Treatment of lupus nephritis: practical issues in Asian countries.Read the original story

    Dec 5, 2014 | CiteULike

    Lupus nephritis is a common and severe manifestation of systemic lupus erythematosus in Asian patients, and is an important cause of renal failure in Asian countries. Immunosuppressive treatments of LN have evolved over the past few decades and resulted in improvements in patient outcomes.

    Comment?

  15. Maintenance therapy of lupus nephritis with mycophenolate or...Read the original story

    Dec 5, 2014 | CiteULike

    The objective of this study was to summarize the comparative efficacy and safety of MMF and AZA as maintenance therapy for LN. Systematic review and meta-analysis of randomized clinical trials of MMF and AZA as maintenance therapy for LN were performed based on a sensitive search.

    Comment?

  16. Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic reviewRead the original story

    Dec 4, 2014 | BioMed Central

    IgA nephropathy is the most common primary glomerular disease worldwide and also the most frequent cause of kidney failure. Mycophenolate mofetil is a selective immunosuppressant widely used in many autoimmune diseases.

    Comment?

  17. Drug Combo Found to Help Lupus PatientsRead the original story w/Photo

    Nov 12, 2014 | News Max

    A combination of drugs may offer a better way to combat a serious kidney complication that commonly affects people with lupus, a new study from China suggests. In a trial of more than 300 Chinese patients with the condition, known as lupus nephritis, those who were given a trio of powerful drugs were more likely to see a complete remission.

    Comment?

  18. Triple drug combo benefits lupus nephritisRead the original story w/Photo

    Nov 11, 2014 | PhysOrg Weblog

    In a trial of 368 Chinese patients with lupus nephritis, those who were given a trio of medications were more likely to see a complete remission. The researchers, led by Zhihong Liu, M.D., of the Nanjing University School of Medicine in China, reported the findings online Nov. 11 in the Annals of Internal Medicine .

    Comment?

  19. Drug Combo Helps Lupus-Related Kidney ConditionRead the original story w/Photo

    Nov 10, 2014 | Mental Help Net

    A combination of drugs may offer a better way to combat a serious kidney complication that commonly affects people with lupus, a new study from China suggests. In a trial of more than 300 Chinese patients with the condition, known as lupus nephritis, those who were given a trio of powerful drugs were more likely to see a complete remission.

    Comment?

  20. Multidrug, multitarget regimen results in higher remission rates for lupus nephritis patientsRead the original story w/Photo

    Nov 10, 2014 | Medical News Today

    A multidrug, multitarget regimen proves superior to intravenous cyclophosphamide as induction therapy for lupus nephritis , according to a randomized, controlled trial being published in Annals of Internal Medicine . LN is the inflammation of the kidney caused by systemic lupus erythematosus.

    Comment?